Technical Analysis for PXXLF - Poxel Sa

Grade Last Price % Change Price Change
grade A 6.1804 2.37% 0.1432
PXXLF closed up 2.37 percent on Tuesday, March 31, 2020, on 12.74 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Down Down
Historical PXXLF trend table...

Date Alert Name Type % Chg
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Narrow Range Bar Range Contraction 0.00%
Strong but Oversold Other 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish 2.37%
Pocket Pivot Bullish Swing Setup 2.37%
Volume Surge Other 2.37%
Older signals for PXXLF ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Poxel SA, a biopharmaceutical company, develops drugs for metabolic diseases with a primary focus on type II diabetes. Its lead product is Imeglimin, an oral anti-diabetic candidate, which is in Phase III clinical development stage that targets the organs of diabetes, such as pancreas, liver, and muscles. The company is also developing PXL770, an adenosine monophosphate-activated protein kinase enzyme, which is in Phase IIa clinical trial that controls body energy metabolism and treats chronic metabolic diseases, such as non-alcoholic steatohepatitis. Poxel SA has a licensing agreement with Enyo Pharmaceuticals for the development of PXL007 (EYP001), an FXR agonist that is in Phase I study for the treatment of Hepatitis B. The company was founded in 2009 and is headquartered in Lyon, France.
Medicine RTT Biopharmaceutical Diabetes Hepatitis Metabolic Diseases Diabetes Mellitus Non Alcoholic Fatty Liver Disease Steatohepatitis Hepatitis B Metabolism Ii Diabetes Intercept Pharmaceuticals Treatment Of Hepatitis B

Is PXXLF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 15.35
52 Week Low 5.85
Average Volume 6,160
200-Day Moving Average 0.0000
50-Day Moving Average 9.0154
20-Day Moving Average 10.2333
10-Day Moving Average 9.6848
Average True Range 0.8279
ADX 23.13
+DI 34.2076
-DI 63.2492
Chandelier Exit (Long, 3 ATRs ) 12.8663
Chandelier Exit (Short, 3 ATRs ) 8.5137
Upper Bollinger Band 15.4878
Lower Bollinger Band 4.9788
Percent B (%b) 0.11
BandWidth 102.6941
MACD Line -0.4324
MACD Signal Line 0.3926
MACD Histogram -0.8251
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 6.1804
Resistance 3 (R3) 6.1804 6.1804 6.1804
Resistance 2 (R2) 6.1804 6.1804 6.1804 6.1804
Resistance 1 (R1) 6.1804 6.1804 6.1804 6.1804 6.1804
Pivot Point 6.1804 6.1804 6.1804 6.1804 6.1804
Support 1 (S1) 6.1804 6.1804 6.1804 6.1804 6.1804
Support 2 (S2) 6.1804 6.1804 6.1804 6.1804
Support 3 (S3) 6.1804 6.1804 6.1804
Support 4 (S4) 6.1804